Citation Impact
Citing Papers
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents
2007 Standout
Serotonin: a review
2008
Animal models of obstetric complications in relation to schizophrenia
2004
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring
2003
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Schizophrenia
2009 Standout
Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
2008
Network pharmacology: the next paradigm in drug discovery
2008 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system
2002
Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats
2003
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
2004
Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
2011
Human volition: towards a neuroscience of will
2008 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Anatomically distinct dopamine release during anticipation and experience of peak emotion to music
2011 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine
2010
Hot flushes
2002
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
The Serotonin Syndrome
2005 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Cortical Cholinergic Transmission and Cortical Information Processing in Schizophrenia
2005
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice
2000
Modeling Sensitization to Stimulants in Humans
2006
Very long-chainn-3 fatty acids and human health: fact, fiction and the future
2017
Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders
2003
Psychosis pathways converge via D2High dopamine receptors
2006
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Stress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study
2007
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression
2014 StandoutNobel
Human Cannabinoid Pharmacokinetics
2007 Standout
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Possible association of β‐arrestin 2 gene with methamphetamine use disorder, but not schizophrenia
2006
Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants
2008
Pivotal mental states
2020
Works of Kunio Yui being referenced
Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex
2002
Studies of Amphetamine or Methamphetamine Psychosis in Japan: Relation of Methamphetamine Psychosis to Schizophrenia
2000
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization
1999
Oseltamivir (Tamiflu®) increases dopamine levels in the rat medial prefrontal cortex
2008
Spontaneous Recurrence of Methamphetamine-lnduced Paranoid-Hallucinatory States in Female Subjects: Susceptibility to Psychotic States and Implications for Relapse of Schizophrenia
2002
Behavioral Responses Induced by Repeated Treatment with Methamphetamine Alone and in Combination with Scopolamine in Rats
1996
Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome
2001
Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats
2008
Methamphetamine Psychosis
1997
Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum Disorders
2012
Increased Sensitivity to Stress in Spontaneous Recurrence of Methamphetamine Psychosis: Noradrenergic Hyperactivity With Contribution From Dopaminergic Hyperactivity
2000
The Role of Noradrenergic and Dopaminergic Hyperactivity in the Development of Spontaneous Recurrence of Methamphetamine Psychosis and Susceptibility to Episode Recurrence
2004
Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex
2004
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis1Institute at which the work was carried out: Department of Legal Medicine and Human Genetics, Jichi Medical School, Minamikawachi, Tochigi 329-0498, Japan, and Medical Care Section, Tochigi Prison, Ministry of Justice, Sozya 2484, Tochigi 328-0002, Japan.1
2001
Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress
2000